These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27109418)

  • 1. Characterization of melt-quenched and milled amorphous solids of gatifloxacin.
    Hattori Y; Suzuki A; Otsuka M
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1851-6. PubMed ID: 27109418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal insight of mechanically activated bile acid powders.
    Ito T; Byrn S; Chen X; Carvajal MT
    Int J Pharm; 2011 Nov; 420(1):68-75. PubMed ID: 21872650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of amorphous states prepared by melt-quenching and cryomilling polymorphs of carbamazepine.
    Guinet Y; Paccou L; Danède F; Willart JF; Derollez P; Hédoux A
    Int J Pharm; 2016 Jul; 509(1-2):305-313. PubMed ID: 27237427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
    Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
    Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in crystallization behavior between quenched and ground amorphous ursodeoxycholic acid.
    Yonemochi E; Inoue Y; Buckton G; Moffat A; Oguchi T; Yamamoto K
    Pharm Res; 1999 Jun; 16(6):835-40. PubMed ID: 10397602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin.
    Trasi NS; Boerrigter SX; Byrn SR
    Pharm Res; 2010 Jul; 27(7):1377-89. PubMed ID: 20490628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling.
    Feng T; Bates S; Carvajal MT
    Int J Pharm; 2009 Feb; 367(1-2):16-9. PubMed ID: 19013224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
    Mah PT; Laaksonen T; Rades T; Aaltonen J; Peltonen L; Strachan CJ
    Mol Pharm; 2014 Jan; 11(1):234-42. PubMed ID: 24224572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin of two modes of non-isothermal crystallization of glasses produced by milling.
    Chattoraj S; Bhugra C; Telang C; Zhong L; Wang Z; Sun CC
    Pharm Res; 2012 Apr; 29(4):1020-32. PubMed ID: 22173781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential scanning calorimetry predicts the critical quality attributes of amorphous glibenclamide.
    Mah PT; Laaksonen T; Rades T; Peltonen L; Strachan CJ
    Eur J Pharm Sci; 2015 Dec; 80():74-81. PubMed ID: 26296864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.
    Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
    Mol Pharm; 2008; 5(6):927-36. PubMed ID: 19434849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability.
    Crowley KJ; Zografi G
    J Pharm Sci; 2002 Feb; 91(2):492-507. PubMed ID: 11835208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
    J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry.
    Otsuka M; Kato F; Matsuda Y
    AAPS PharmSciTech; 2002; 3(4):E30. PubMed ID: 12916924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase transformations undergone by Triton X-100 probed by differential scanning calorimetry and dielectric relaxation spectroscopy.
    Merino EG; Rodrigues C; Viciosa MT; Melo C; Sotomayor J; Dionísio M; Correia NT
    J Phys Chem B; 2011 Nov; 115(43):12336-47. PubMed ID: 21928821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.
    Greco K; Bogner R
    Mol Pharm; 2010 Oct; 7(5):1406-18. PubMed ID: 20459092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
    Aucamp M; Milne M; Liebenberg W
    AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
    Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
    J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.